WO2006002763A3 - Substituierte tetrahydroisochinoline als mmp-inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament - Google Patents
Substituierte tetrahydroisochinoline als mmp-inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament Download PDFInfo
- Publication number
- WO2006002763A3 WO2006002763A3 PCT/EP2005/006415 EP2005006415W WO2006002763A3 WO 2006002763 A3 WO2006002763 A3 WO 2006002763A3 EP 2005006415 W EP2005006415 W EP 2005006415W WO 2006002763 A3 WO2006002763 A3 WO 2006002763A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- drags
- tetrahydroisochinolines
- substituted
- production
- mmp inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05757350A EP1763516A2 (de) | 2004-06-30 | 2005-06-15 | Substituierte tetrahydroisochinoline als mmp-inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament |
CA002572125A CA2572125A1 (en) | 2004-06-30 | 2005-06-15 | Substituted tetrahydroisochinolines used in the form of mmp inhibitors, method for the production and use thereof in the form of drags |
BRPI0511323-7A BRPI0511323A (pt) | 2004-06-30 | 2005-06-15 | tetraidroisoquinolinas substituìdas usadas na forma de inibidores de mmp, método para a produção e uso das mesmas na forma de drágeas |
AU2005259633A AU2005259633A1 (en) | 2004-06-30 | 2005-06-15 | Substituted tetrahydroisochinolines used in the form of MMP inhibitors, method for the production and use thereof in the form of drags |
MXPA06014366A MXPA06014366A (es) | 2004-06-30 | 2005-06-15 | Tetrahidroisoquinolinas sustituidas utilizadas en forma de inhibidores de mpm, metodo para su produccion y su uso en forma de farmacos. |
JP2007518484A JP2008504315A (ja) | 2004-06-30 | 2005-06-15 | Mmp阻害剤の形態で使用される置換テトラヒドロイソキノリン、その製造法および薬剤としての使用 |
IL179974A IL179974A0 (en) | 2004-06-30 | 2006-12-11 | Substituted tetrahydroiso quinolines used in the form of mmp inhibitors, method for the production and use thereof in the form of drugs |
US11/612,938 US20070203118A1 (en) | 2004-06-30 | 2006-12-19 | Substituted tetrahydroisoquinolines used in the form of mmp inhibitors, method for the production and use thereof in the form of drugs |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004031850.6 | 2004-06-30 | ||
DE102004031850A DE102004031850A1 (de) | 2004-06-30 | 2004-06-30 | Substituirte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/612,938 Continuation US20070203118A1 (en) | 2004-06-30 | 2006-12-19 | Substituted tetrahydroisoquinolines used in the form of mmp inhibitors, method for the production and use thereof in the form of drugs |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006002763A2 WO2006002763A2 (de) | 2006-01-12 |
WO2006002763A3 true WO2006002763A3 (de) | 2006-03-16 |
Family
ID=34971773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/006415 WO2006002763A2 (de) | 2004-06-30 | 2005-06-15 | Substituierte tetrahydroisochinoline als mmp-inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070203118A1 (de) |
EP (1) | EP1763516A2 (de) |
JP (1) | JP2008504315A (de) |
KR (1) | KR20070026679A (de) |
CN (1) | CN101006059A (de) |
AU (1) | AU2005259633A1 (de) |
BR (1) | BRPI0511323A (de) |
CA (1) | CA2572125A1 (de) |
DE (1) | DE102004031850A1 (de) |
IL (1) | IL179974A0 (de) |
MX (1) | MXPA06014366A (de) |
PE (1) | PE20060458A1 (de) |
TW (1) | TW200612940A (de) |
UY (1) | UY28993A1 (de) |
WO (1) | WO2006002763A2 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004031620A1 (de) * | 2004-06-30 | 2006-02-02 | Sanofi-Aventis Deutschland Gmbh | 4-Trifluormethoxyphenoxybenzol-4`-sulfonsäuren, Verfahren zu ihrer Herstellung und Verwendung in Arzneimitteln |
DE102005015040A1 (de) * | 2005-03-31 | 2006-10-05 | Sanofi-Aventis Deutschland Gmbh | Substituierte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
GB0706072D0 (en) | 2007-03-28 | 2007-05-09 | Sterix Ltd | Compound |
AU2016226340B2 (en) * | 2015-03-02 | 2019-11-07 | Amgen Inc. | Bicyclic ketone sulfonamide compounds |
TWI650313B (zh) * | 2017-09-08 | 2019-02-11 | 財團法人國家衛生研究院 | 雜環化合物及其用途 |
US10597378B2 (en) | 2017-09-08 | 2020-03-24 | National Health Research Institutes | Tetrahydroisoquinolines for use as MOR/NOP dual agonists |
CN110835639B (zh) * | 2018-08-16 | 2021-08-10 | 苏州同力生物医药有限公司 | 一种制备(s)-1,2,3,4-四氢异喹啉-1-甲酸及其衍生物的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997018194A1 (de) * | 1995-11-13 | 1997-05-22 | Hoechst Aktiengesellschaft | CYCLISCHE UND HETEROCYCLISCHE N-SUBSTITUIERTE α-IMINOHYDROXAM- UND CARBONSÄUREN |
WO2005030728A1 (de) * | 2003-09-27 | 2005-04-07 | Sanofi-Aventis Deutschland Gmbh | Bicyclische iminosäurederivate als inhibitoren von matrix-metalloproteinasen |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19542189A1 (de) * | 1995-11-13 | 1997-05-15 | Hoechst Ag | Cyclische N-substituierte alpha-Iminohydroxamsäuren |
WO2003016248A2 (en) * | 2001-08-17 | 2003-02-27 | Bristol-Myers Squibb Company Patent Department | Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace) |
US7205315B2 (en) * | 2003-09-27 | 2007-04-17 | Sanofi-Aventis Deutschland Gmbh | Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases |
-
2004
- 2004-06-30 DE DE102004031850A patent/DE102004031850A1/de not_active Ceased
-
2005
- 2005-06-15 CN CNA2005800220960A patent/CN101006059A/zh active Pending
- 2005-06-15 WO PCT/EP2005/006415 patent/WO2006002763A2/de not_active Application Discontinuation
- 2005-06-15 MX MXPA06014366A patent/MXPA06014366A/es not_active Application Discontinuation
- 2005-06-15 CA CA002572125A patent/CA2572125A1/en not_active Abandoned
- 2005-06-15 KR KR1020067027661A patent/KR20070026679A/ko not_active Application Discontinuation
- 2005-06-15 JP JP2007518484A patent/JP2008504315A/ja not_active Abandoned
- 2005-06-15 AU AU2005259633A patent/AU2005259633A1/en not_active Abandoned
- 2005-06-15 EP EP05757350A patent/EP1763516A2/de not_active Withdrawn
- 2005-06-15 BR BRPI0511323-7A patent/BRPI0511323A/pt not_active IP Right Cessation
- 2005-06-16 PE PE2005000688A patent/PE20060458A1/es not_active Application Discontinuation
- 2005-06-28 TW TW094121519A patent/TW200612940A/zh unknown
- 2005-06-30 UY UY28993A patent/UY28993A1/es unknown
-
2006
- 2006-12-11 IL IL179974A patent/IL179974A0/en unknown
- 2006-12-19 US US11/612,938 patent/US20070203118A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997018194A1 (de) * | 1995-11-13 | 1997-05-22 | Hoechst Aktiengesellschaft | CYCLISCHE UND HETEROCYCLISCHE N-SUBSTITUIERTE α-IMINOHYDROXAM- UND CARBONSÄUREN |
WO2005030728A1 (de) * | 2003-09-27 | 2005-04-07 | Sanofi-Aventis Deutschland Gmbh | Bicyclische iminosäurederivate als inhibitoren von matrix-metalloproteinasen |
Non-Patent Citations (10)
Title |
---|
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; MA, DAWEI ET AL: "Preparation of 2-arylsulfonyltetrahydroisoquinoline hydroximic acid derivs. as matrix metalloproteinase inhibitors", XP002345111, retrieved from STN Database accession no. 2003:779616 * |
KAELLBLAD, PER ET AL: "Receptor Flexibility in the in Silico Screening of Reagents in the S1' Pocket of Human Collagenase", JOURNAL OF MEDICINAL CHEMISTRY , 47(11), 2761-2767 CODEN: JMCMAR; ISSN: 0022-2623, 20 May 2004 (2004-05-20), XP002356826 * |
KANG, IOU-JIUN ET AL: "Synthesis of ethyl 1,2,3,4-tetrahydroisoquinoline-1-carboxylates by Pictet-Spengler condensation using phenyliodine(III) bis(trifluoroacetate)", HETEROCYCLES , 57(1), 1-4 CODEN: HTCYAM; ISSN: 0385-5414, 2002, XP008052601 * |
KOHNO, HARUMICHI ET AL: "A novel cyclization of electron deficient N-benzenesulfonyl-.beta.- phenethylamines using ethyl chloro(methylthio)acetate. Synthesis of ethyl 1,2,3,4-tetrahydroisoquinoline-1-carboxylates", HETEROCYCLES , 42(1), 141-4 CODEN: HTCYAM; ISSN: 0385-5414, 1996, XP008052599 * |
KOHNO, HARUMICHI ET AL: "A novel synthesis of isoquinolines containing an electron withdrawing substituent", HETEROCYCLES , 51(1), 103-117 CODEN: HTCYAM; ISSN: 0385-5414, 1999, XP008052600 * |
LEE, CHAI HO ET AL: "Intra- and intermolecular .alpha.-sulfamidoalkylation reactions", JOURNAL OF ORGANIC CHEMISTRY , 55(25), 6098-104 CODEN: JOCEAH; ISSN: 0022-3263, 1990, XP002345109 * |
LUKANOV, LUDMIL K. ET AL: "Synthesis of 2-acyltetrahydroisoquinolines and 2-acyl-1,2,3,4- tetrahydro-1,2-benzothiazine-1,1-diones by electrophilic substitution reactions of N-acyl-2-phenylethylamines", SYNTHETIC COMMUNICATIONS , 28(12), 2137-2147 CODEN: SYNCAV; ISSN: 0039-7911, 1998, XP008052591 * |
MA, DAWEI ET AL: "Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS , 14(1), 47-50 CODEN: BMCLE8; ISSN: 0960-894X, 5 January 2004 (2004-01-05), XP002345108 * |
SILVEIRA, CLAUDIO C. ET AL: "Pictet-Spengler condensation of N-sulfonyl-.beta.-phenethylamines with .alpha.-chloro-.alpha.-phenylselenoesters. New synthesis of 1,2,3,4-tetrahydroisoquinoline-1-carboxylates", TETRAHEDRON LETTERS , 40(27), 4969-4972 CODEN: TELEAY; ISSN: 0040-4039, 1999, XP004169372 * |
WANG, HUEY-MIN ET AL: "Ytterbium triflate-catalysed synthesis of ethyl 1,2,3,4- tetrahydroisoquinoline-1-carboxylates using ethyl chloro(phenylselanyl)acetate", HETEROCYCLES , 60(8), 1899-1905 CODEN: HTCYAM; ISSN: 0385-5414, 2003, XP008052602 * |
Also Published As
Publication number | Publication date |
---|---|
CA2572125A1 (en) | 2006-01-12 |
AU2005259633A1 (en) | 2006-01-12 |
KR20070026679A (ko) | 2007-03-08 |
EP1763516A2 (de) | 2007-03-21 |
PE20060458A1 (es) | 2006-05-29 |
UY28993A1 (es) | 2006-01-31 |
CN101006059A (zh) | 2007-07-25 |
JP2008504315A (ja) | 2008-02-14 |
IL179974A0 (en) | 2007-05-15 |
US20070203118A1 (en) | 2007-08-30 |
MXPA06014366A (es) | 2007-03-08 |
BRPI0511323A (pt) | 2007-12-04 |
WO2006002763A2 (de) | 2006-01-12 |
TW200612940A (en) | 2006-05-01 |
DE102004031850A1 (de) | 2006-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL300933I2 (nl) | Letermovir | |
GEP20125537B (en) | Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors | |
EA201000563A1 (ru) | Триазолпиридиновые ингибиторы 11-бета- гидроксистероид - дегидрогеназы типа i | |
MXPA06012595A (es) | Analogos de amino-tetrazoles y metodos de uso. | |
RS95404A (en) | Thiazolidinones and the use thereof as polo-like kinase inhibitors | |
UA85707C2 (ru) | Бензоксазины для лечения заболеваний дыхательных путей | |
WO2006002763A3 (de) | Substituierte tetrahydroisochinoline als mmp-inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament | |
WO2007023110A3 (en) | P38 map kinase inhibitors and methods for using the same | |
SE0301886D0 (sv) | New use V | |
WO2007120980A3 (en) | 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases | |
WO2008075068A3 (en) | Acylaminopyrazoles as fgfr inhibitors | |
WO2006028958A3 (en) | Pyridyl inhibitors of hedgehog signalling | |
NO20083036L (no) | Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av depresjon | |
EP1889842A4 (de) | Heterozyklische verbindung | |
NO20070526L (no) | Kinazolindionderivater som parp-inhibitorer | |
WO2008079339A3 (en) | Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections | |
WO2006116733A3 (en) | Protein kinase inhibitors | |
TNSN06138A1 (fr) | Inhibitors of the mutant form of kit | |
NO20062453L (no) | Tiozolidinoner, fremstilling og anvendelse derav som legemidler | |
WO2006014282A3 (en) | Prodrugs of hiv protease inhibitors | |
SE0301232D0 (sv) | Novel use | |
PL1685142T3 (pl) | Pochodne kwasu fosfinowego, inhibitory beta-sekterazy do leczenia choroby Alzheimera | |
TW200634013A (en) | Quinoline derivative, its use, production and pharmaceutical agents containing the derivative | |
TW200613292A (en) | Benzothiazolium compounds | |
TW200628458A (en) | Metasubstituted thiazolidinones, their manufacture and use as a drug |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2006/014366 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 179974 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005757350 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11612938 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005259633 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 4762/CHENP/2006 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007518484 Country of ref document: JP Ref document number: 1020067027661 Country of ref document: KR Ref document number: 2572125 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580022096.0 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
ENP | Entry into the national phase |
Ref document number: 2005259633 Country of ref document: AU Date of ref document: 20050615 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005259633 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 1020067027661 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2005757350 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 11612938 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: PI0511323 Country of ref document: BR |